Skip to content

Live TV Markets Finance Economics Industries Tech Real Estate Small Business Politics Video

Top SecuritiesDOW (DIA) $522.57 ▼0.36%S&P 500 (SPY) $757.25 ▼0.34%NASDAQ 25,366 ▼0.39%10Y 5.10% ▲12 bp BITCOIN $69,007 ▼3.43%NASDAQ 100 (QQQ) $688.17 ▼0.32%30Y MORTGAGE 7.11% ▼0.07

Thursday, November 12, 2026 Edition · Raleigh 52° Mostly Clear Watch Live Sign in Subscribe

Genius Eye News A service of The GET Network, Inc.

Markets

DOW (DIA) $522.57 -0.36%S&P 500 (SPY) $757.25 -0.34%NASDAQ 25,366 -0.39%10Y 5.10% +12 bpBITCOIN $69,007 -3.43%NASDAQ 100 (QQQ) $688.17 -0.32%30Y MORTGAGE 7.11% -0.07Democrats gain Senate seats with strong Charleston support in 2026 election No. 1 South Carolina women's basketball beats Clemson 65-44 for 16th straight win Dominion-NextEra merger prompts North Charleston customers to voice concerns USS George H.W. Bush deployment extended, families face up to year apart Bangkok hosts first Eurovision Song Contest Asia to boost tourism Cade Cunningham scores 52 points as Pistons win double-OT thriller against Wizards Animator Michael John Roberts of ‘BoJack Horseman’ dies at 48 James Island quarterback Brady Dantzler commits to East CarolinaDOW (DIA) $522.57 -0.36%S&P 500 (SPY) $757.25 -0.34%NASDAQ 25,366 -0.39%10Y 5.10% +12 bpBITCOIN $69,007 -3.43%NASDAQ 100 (QQQ) $688.17 -0.32%30Y MORTGAGE 7.11% -0.07Democrats gain Senate seats with strong Charleston support in 2026 election No. 1 South Carolina women's basketball beats Clemson 65-44 for 16th straight win Dominion-NextEra merger prompts North Charleston customers to voice concerns USS George H.W. Bush deployment extended, families face up to year apart Bangkok hosts first Eurovision Song Contest Asia to boost tourism Cade Cunningham scores 52 points as Pistons win double-OT thriller against Wizards Animator Michael John Roberts of ‘BoJack Horseman’ dies at 48 James Island quarterback Brady Dantzler commits to East Carolina

San Jose

Kodiak Sciences in Palo Alto to present at investor conferences

Palo Alto-based Kodiak Sciences will share updates on late-stage retinal disease treatments at upcoming investor events.

Nov 11, 2026, 9:27 PM By the Genius Eye newsroom (City Reporter) · Fact-checkedHow we report

Photo: Michael from San Jose, California, USA / CC BY 2.0, via Wikimedia Commons

Kodiak Sciences Inc., a biotechnology company based in Palo Alto focused on retinal diseases, announced it will present at three investor conferences in November and December 2026, according to a company press release on PR Newswire.

The company specializes in developing new retinal medicines aimed at preventing and treating major causes of blindness worldwide, including wet age-related macular degeneration and diabetic retinopathy.

Kodiak Sciences is advancing three late-stage clinical programs: Zenkuda™, KSI-501, and KSI-101, targeting a market valued at $15 billion related to anti-VEGF therapies for retinal vascular diseases.

Topline data for one of their Phase 3 studies, PEAK, is expected in December 2026, with additional data from the PINNACLE study anticipated in the second quarter of 2027.

Live webcasts of the presentations will be accessible on Kodiak Sciences' investor relations website, with replays available for a limited time after each event.

Share:Facebook X Threads LinkedIn WhatsApp Text Email Copy link (Instagram, TikTok)

Sources

prnewswire.com: Kodiak Sciences to Present at Three Upcoming Investor Conferences

We read public reporting and official data, confirm what we can, and write our own story. See something wrong? Request a correction.

Comments

No comments yet.

Sign in to comment